CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Trends Analyst Outlook Journalist POV

58 hedge funds and large institutions have $46M invested in CASI Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

36% less capital invested

Capital invested by funds: $72.3M → $46M (-$26.3M)

50% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 20

Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$869K
2
+$867K
3
+$287K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$276K
5
CSS
Cubist Systematic Strategies
Connecticut
+$235K

Top Sellers

1
-$10.4M
2
-$422K
3
-$355K
4
TEE
Tibra Equities Europe
United Kingdom
-$335K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$206K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$5K
52
$2.21K
53
$2K
54
$2K
55
$2K
56
$1K
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3